CPIX vs. DNTH
CPIX (Cumberland Pharmaceuticals Inc.) and DNTH (Dianthus Therapeutics Inc.) are both stocks. Both are in the Healthcare sector — CPIX in Drug Manufacturers - Specialty & Generic, DNTH in Biotechnology. Over the past year, CPIX returned 89.77% vs 419.28% for DNTH. Their 0.05 correlation means their historical movements had little consistent relationship.
Performance
CPIX vs. DNTH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CPIX achieves a 67.84% return, which is significantly lower than DNTH's 159.45% return.
CPIX
- 1D
- -0.74%
- 1M
- 4.87%
- 6M
- 78.13%
- YTD
- 67.84%
- 1Y
- 89.77%
- 3Y*
- 66.39%
- 5Y*
- 15.50%
- 10Y*
- 3.85%
- ALL TIME*
- -5.36%
DNTH
- 1D
- -5.08%
- 1M
- 13.33%
- 6M
- 100.26%
- YTD
- 159.45%
- 1Y
- 419.28%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 124.41%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $942.95K | $842.80K | $677.16K | |
| $89.59M | $95.14M | $92.66M |
CPIX vs. DNTH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
CPIX Cumberland Pharmaceuticals Inc. | 67.84% | 67.93% | 32.28% | 9.25% |
DNTH Dianthus Therapeutics Inc. | 159.45% | 89.04% | 109.62% | 0.00% |
Correlation
The correlation between CPIX and DNTH is 0.11, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.11 |
Correlation (All Time) Calculated using the full available price history since Sep 12, 2023 | 0.05 |
Fundamentals
CPIX:
$100.09M
DNTH:
$4.46B
CPIX:
-$0.49
DNTH:
-$0.45
CPIX:
2.38
DNTH:
3.09K
CPIX:
$41.94M
DNTH:
$873.00K
CPIX:
$34.76M
DNTH:
$873.00K
CPIX:
-$3.18M
DNTH:
-$187.38M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CPIX vs. DNTH — Risk / Return Rank
CPIX
DNTH
CPIX vs. DNTH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cumberland Pharmaceuticals Inc. (CPIX) and Dianthus Therapeutics Inc. (DNTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CPIX | DNTH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -5.27 | ||
| Sortino ratioReturn per unit of downside risk | -3.55 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.69 | -0.45 |
| Calmar ratioReturn relative to maximum drawdown | 1.79 | 20.83 | -19.04 |
| Martin ratioReturn relative to average drawdown | 3.71 | 53.91 | -50.20 |
Loading charts...
Drawdowns
CPIX vs. DNTH - Drawdown Comparison
The maximum CPIX drawdown since its inception was -93.78%, which is greater than DNTH's maximum drawdown of -53.48%. Use the drawdown chart below to compare losses from any high point for CPIX and DNTH.
Loading charts...
Drawdown Indicators
| CPIX | DNTH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.78% | -53.48% | -40.30% |
Max Drawdown (1Y)Largest decline over 1 year | -52.62% | -20.20% | -32.42% |
Max Drawdown (3Y)Largest decline over 3 years | -71.94% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -84.73% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -86.68% | — | — |
Current DrawdownCurrent decline from peak | -60.81% | -5.08% | -55.73% |
Average DrawdownAverage peak-to-trough decline | -70.69% | -17.26% | -53.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.34% | 7.79% | +17.55% |
Volatility
CPIX vs. DNTH - Volatility Comparison
Cumberland Pharmaceuticals Inc. (CPIX) has a higher volatility of 29.50% compared to Dianthus Therapeutics Inc. (DNTH) at 18.40%. This indicates that CPIX's price experiences larger fluctuations and is considered to be riskier than DNTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CPIX | DNTH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.50% | 18.40% | +11.10% |
Volatility (6M)Calculated over the trailing 6-month period | 60.76% | 45.89% | +14.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 88.18% | 66.42% | +21.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 115.14% | 76.88% | +38.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 87.01% | 76.88% | +10.13% |
Dividends
CPIX vs. DNTH - Dividend Comparison
Neither CPIX nor DNTH has paid dividends to shareholders.
Financials
CPIX vs. DNTH - Financials Comparison
This section allows you to compare key financial metrics between Cumberland Pharmaceuticals Inc. and Dianthus Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CPIX and DNTH have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CPIX has higher volatility (29.50%) compared to DNTH (18.40%). In terms of maximum drawdown, CPIX dropped -93.78% vs DNTH's -53.48%.
DNTH currently has the higher Sharpe Ratio (6.33 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CPIX and DNTH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer